On a cloudy day in a nondescript building in Los Angeles, Decrypt was invited to take a closer look at a technology that purports to use artificial intelligence to help doctors better identify cancer cells in the body. The tech is being developed by New York-based medical technology company Ezra, and the company offered a first-hand, hands-on experience with the Ezra MRI scanner.
With pervasive medical conditions like cancer seemingly spreading further and wider each year, Ezra says it’s targeting a narrower—but important—constituency. Early detection of cancer is crucial in treating and surviving the deadly disease, and Ezra says it is making diagnosing and treatment more accessible and faster using full-body scans and artificial intelligence.
“[Early detection] makes a huge difference for every patient, and it also makes a huge difference for the medical system,” Ezra’s medical advisor, Dr. Daniel Sodickson, told Decrypt. “It’s been shown that the five-year survival rates for cancer jumped from 20% to 80%, on average, if it’s caught early, so if you do the numbers, that’s something like a billion lives saved.”
Sodickson says the key to early detection is a full body scan, rather than just focusing on one area of the body or symptom. According to Ezra, the scanner targets several significant areas, including the brain, thyroid, uterus, prostate, lungs, liver, and kidneys.
Go to Source to See Full Article
Author: Jason Nelson
Tip BTC Newswire with Cryptocurrency